Concepedia

S. Neslihan Alpay

SN

Statistics

Publications

6

Citations

496

H-Index

6

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Al-Azhar University

S. Neslihan Alpay is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, tumor biology, and cell biology.

Top concepts

Publications per year

2012–2015

6

Publications

6

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer

İbrahim Tekedereli, S. Neslihan Alpay, Clint D.J. Tavares et al. · PLoS ONE · 2012 · 117 citations · Full text

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer

İbrahim Tekedereli, S. Neslihan Alpay, Uǧur Akar et al. · Molecular Therapy — Nucleic Acids · 2013 · 99 citations · Full text

Erythropoietin Stimulates Tumor Growth via EphB4

Sunila Pradeep, Jie Huang, Edna Mora et al. · Cancer Cell · 2015 · 96 citations · Full text

, , +4

Elongation factor‐2 kinase regulates <scp>TG</scp>2/β1 integrin/Src/u<scp>PAR</scp> pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion

Ahmed A. Ashour, Nilgün Gürbüz, S. Neslihan Alpay et al. · Journal of Cellular and Molecular Medicine · 2014 · 88 citations · Full text

Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells

Ahmed A. Ashour, Abdel‐Aziz H. Abdel‐Aziz, Ahmed M. Mansour et al. · APOPTOSIS · 2013 · 86 citations

, , +11

1–5 of 6